Direct Intrahepatic Portacaval Shunt:Initial Results of 6 Patients

罗剑钧,颜志平,周康荣,钱晟,吴安乐,陈颐

DOI: https://doi.org/10.3760/j.issn:1005-1201.2004.01.009

2004-01-01

Abstract:Objective To evaluate the feasibility and safety of creating direct intrahepatic portacaval shunt (DIPS) between retrohepatic segment of inferior vena cava (RHSIVC) and portal vein with puncturing under sonographic guidance Methods DIPS was created in 6 patients with portal hypertension under sonographic guidance One of the 3 patients with hepatic carcinoma was treated by hepatic arterial chemoembolization (HACE) simultaneously Every patient undertook upper abdominal enhanced CT examination before procedure to measure the length and diameter of RHSIVC and the extension of RHSIVC encircled by the surrounding hepatic parenchyma Patient’s erythrocyte and haemoglobin counts,hepatic function,serum NH 3 level,and pressure of portal vein were compared before and after DIPS ,respectively Patency of shunt was followed by Doppler-US Results 6 DIPS were successfully created in all patients After DIPS,the pressure of portal vein was declined from (30 83±3 19) mm Hg(1 mm Hg=0 133 kPa) to (18 50±6 47) mm Hg One patient with HCC who was treated by HACE simultaneously had complication of acute hepatic failure and died 3 days after procedure,the remaining 5 patients had no serious procedure-related complications The DIPS shunt of 5 survival patients was kept patent for 30- 150 days (median patent time was 60 days) Conclusion Our initial experience demonstrated that direct intrahepatic portosystemic shunt seemed to be a feasible and safe procedure to treat portal hypertension Further study will be necessary to generalize DIPS procedure clinically